A critical breakthrough in cancer study is occurring with the use of VHH fragments to reactivate damaged p53. This crucial tumor protector protein is frequently lost in various types of malignancies, causing https://socialmediaentry.com/story7473647/nanobodies-reactivate-tumor-suppressor-p53-the-promising-hope-for-malignant-therapy